Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Measuring brain atrophy in patients with mild cognitive impairment

Measuring brain atrophy in patients with mild cognitive impairment

June 17, 2009

New, automated way of measuring brain structures appears effective in predicting progression to Alzheimer's Disease

Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease. The procedure can be readily used in clinics to measure brain atrophy, and may help physicians to predict decline in MCI patients. Their study has been published in the June issue of the journal Alzheimer Disease and Associated Disorders.




"Use of this procedure is like bringing the experience of an expert neuro-radiologist to any clinic that has the right software," said James Brewer, MD, PhD, assistant professor in UC San Diego's Departments of Radiology and Neurosciences. "These fully automated and rapid methods of measuring medial temporal lobe volumes may help clinicians predict cognitive decline in their patients, and have the potential to influence how neurology is practiced."

Mild cognitive impairment (MCI) is considered a transitional stage between the forgetfulness associated with normal aging and Alzheimer's disease. Yet, many patients with MCI do not progress to Alzheimer's, and these individuals don't need treatments targeted to prevent or slow down neuro-degeneration. Therefore, objective measures are necessarily to distinguish MCI patients who will clinically decline from those who will remain stable.

"Our goal was to find neuroimaging measures of change that reflected more than merely a person's advancing age, but instead correlated tightly with how a person's cognitive status worsens over time," said co-author Michael Rafii, MD, PhD, assistant professor of neurosciences at UC San Diego. "It's too early to draw a definitive comparison, but it appears that these early changes - especially shrinking of the hippocampus - may offer a robust biological marker for change."

Medial temporal lobe atrophy has been associated with increased risk for conversion of MCI to Alzheimer's disease. However, until now, studies have focused only on measurements of the brain's hippocampus. The extent to which volumes of the amygdala - the section of the brain associated with emotions - and the nearby temporal horn could predict cognitive decline was unknown.

In addition, methods to measure these parts of the brain relied on subjective assessments of MRIs using a "tracing technique" that literally required a drawing of these portions of the brain - a technique that isn't practical or possible in most clinical settings.

For more than a year, researchers at the Memory Disorders Clinic at UC San Diego Medical Center have been successfully using a fully computerized procedure that takes images from the MRI scanner and translates them into quantitative values, according to Rafii, the clinic's director. UC San Diego was the first clinic site to use this technology, which is now starting to be used in other clinical settings throughout the country.

The study looked at the fully automated volume measures of 269 MCI patients over a six-month interval. Baseline volume measurements of the hippocampus, amygdala and temporal horn were evaluated as predictors of cognitive change as measured by two commonly used instruments for screening cognitive function and dementia. Patients with smaller volumes of the hippocampus and amygdala showed more rapid clinical decline on these tests.

"These values objectively measure the hippocampus and amydala, and early data confirm previous findings that these brain areas may atrophy early in Alzheimer's disease and can offer a clinical marker for change," said Rafii. The fluid-filled temporal horn increases as the hippocampus shrinks, and these complementary measurements may correlate closely with how a patient's cognitive status worsens over time, he added.

University of California - San Diego



Related Mild Cognitive Impairment Current Events and Mild Cognitive Impairment News Articles Mild Cognitive Impairment Current Events and Mild Cognitive Impairment News RSS Mild Cognitive Impairment Current Events and Mild Cognitive Impairment News RSS
Chemobrain - the flip side of surviving cancer
One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.

High fruit and vegetable intake positively correlated with antioxidant status, cognitive performance
Researchers at the Institute of Biochemistry and Molecular Biology I of the Heinrich-Heine University, Düsseldorf, Germany, investigated the relationship between fruit and vegetable intake, plasma antioxidant micronutrient status and cognitive performance in healthy subjects aged 45 to 102 years.

Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer's disease
UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease.

Phase 3 Alzheimer's drug increases toxic beta amyloid in the brain -- but still provides benefits
New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.

Regular moderate alcohol intake has cognitive benefits in older adults
A glass of wine here, a nightcap there - new research out of Wake Forest University School of Medicine suggests that moderate alcohol intake offers long-term cognitive protection and reduces the risk of dementia in older adults.

UCLA scientists identify how immune cells may help predict Alzheimer's risk
What if you could test your risk for Alzheimer's disease much like your cholesterol levels - through a simple blood test?

Brain imaging and proteins in spinal fluid may improve Alzheimer's prediction and diagnosis
Changes in the brain measured with MRI and PET scans, combined with memory tests and detection of risk proteins in body fluids, may lead to earlier and more accurate diagnosis of Alzheimer's.

Memory test and PET scans detect early signs of Alzheimer's
A large study of patients with mild cognitive impairment revealed that results from cognitive tests and brain scans can work as an early warning system for the subsequent development of Alzheimer's disease.

Mayo Clinic study continues to refine most effective methods to predict Alzheimer's disease
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test.

Doctors talk frankly about what encourages and impedes early diagnosis of Alzheimer's
A doctor's positive attitude to Alzheimer's diagnosis and their trusting, personal relationships with local dementia support service providers are powerful enablers for early diagnosis of Alzheimer's.
More Mild Cognitive Impairment Current Events and Mild Cognitive Impairment News Articles
Mild Cognitive Impairment: Aging to Alzheimer's Disease (Medicine)

Mild Cognitive Impairment: Aging to Alzheimer's Disease (Medicine)
by Ronald C. Petersen (Editor)

What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions...

Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis

Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis
by Jeffrey Burns (Author), John Morris (Author)

Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource that assists them in identifying those MCI patients who will progress to recognised Alzheimer’s Disease.

Beautifully presented in full colour, Early Diagnosis and Treatment of Mild Cognitive Impairment includes case studies and discusses future therapeutic and diagnostic strategies. It is an invaluable resource for postgraduates and professionals, for specialist physicians in neurology...

Perspectives on Mild Cognitive Impairment (Studies on Neuropsychology, Neurology and Cognition)

Perspectives on Mild Cognitive Impairment (Studies on Neuropsychology, Neurology and Cognition)
by Holly A. Tuokko (Author), David F. Hultsch (Author)

Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time.

This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI. Clinical investigators initially defined mild cognitive impairment (MCI) as a transitional condition between normal aging and the early stages of...

Inefficient response inhibition in individuals with mild cognitive impairment [An article from: Neuropsychologia]

Inefficient response inhibition in individuals with mild cognitive impairment [An article from: Neuropsychologia]
by S.A. Wylie (Author), K.R. Ridderinkhof (Author), M.K. Eckerle (Author), Manni (Author)

This digital document is a journal article from Neuropsychologia, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Individuals diagnosed with mild cognitive impairment (MCI) show primary deficits in memory and are at increased risk for developing Alzheimer's disease (AD). In light of recent evidence that executive cognitive deficits are common in AD and may be detectable in individuals diagnosed with MCI, we extend these findings to the investigation of response inhibition, an essential aspect of executive cognitive control. Twenty MCI patients and 20 healthy controls (HC) completed an arrow version of the flanker task [Eriksen,...

Clinician's Manual on Mild Cognitive Impairment

Clinician's Manual on Mild Cognitive Impairment
by J. Golomb (Author), A. Kluger (Author), P. Garrad (Author), SH. Ferris (Author)



  10 ways to cope with mild cognitive impairment: learning these simple strategies to help you adapt to your changing memory performance can help you minimize ... An article from: Mind, Mood & Memory
by Gale Reference Team (Author)

This digital document is an article from Mind, Mood & Memory, published by Thomson Gale on December 1, 2006. The length of the article is 1195 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: 10 ways to cope with mild cognitive impairment: learning these simple strategies to help you adapt to your changing memory performance can help you minimize confusion and frustration.
Author: Gale Reference Team
Publication: Mind, Mood & Memory (Magazine/Journal)
Date: December 1, 2006
Publisher: Thomson Gale
Volume: 2 Issue: 12 Page: 4(2)

Distributed by Thomson...

  Mild cognitive impairment is widespread. (People Over Age 70).: An article from: Clinical Psychiatry News
by Miriam E. Tucker (Author)

This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on November 1, 2002. The length of the article is 2622 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Mild cognitive impairment is widespread. (People Over Age 70).
Author: Miriam E. Tucker
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: November 1, 2002
Publisher: International Medical News Group
Volume: 30 Issue: 11 Page: 45(1)

Distributed by Thomson...

  Dysgraphia in Alzheimer's disease with mild cognitive impairment.: An article from: Journal of Medical Speech - Language Pathology
by Sunita Kavrie (Author), Jean Neils-Strunjas (Author)

This digital document is an article from Journal of Medical Speech - Language Pathology, published by Delmar Learning on March 1, 2002. The length of the article is 5905 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Dysgraphia in Alzheimer's disease with mild cognitive impairment.
Author: Sunita Kavrie
Publication: Journal of Medical Speech - Language Pathology (Refereed)
Date: March 1, 2002
Publisher: Delmar Learning
Volume: 10 Issue: 1 Page: 73(10)

Distributed by Thomson...

Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment [An article from: Brain and Cognition]

Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment [An article from: Brain and Cognition]
by E.J. Levinoff (Author), D. Saumier (Author), H. Chertkow (Author)

This digital document is a journal article from Brain and Cognition, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Reaction time (RT) tasks take various forms, and can assess psychomotor speed, (i.e., simple reaction time task), and focused attention (i.e., choice reaction time (CRT) task). If cues are provided before stimulus presentation (i.e., cued choice reaction time (CCRT) task), then a cueing effect can also be assessed. A limited number of studies have addressed the nature of focused attention impairments in Alzheimer's disease (AD). Additionally, it is unknown whether similar impairments occur in Mild Cognitive...

  SSRIs are associated with mild cognitive impairment. (Watch Geriatric Patients Closely).(selective serotonin reuptake inhibitors)(Brief Article): An article from: Clinical Psychiatry News
by Carl Sherman (Author)

This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on April 1, 2002. The length of the article is 2767 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: SSRIs are associated with mild cognitive impairment. (Watch Geriatric Patients Closely).(selective serotonin reuptake inhibitors)(Brief Article)
Author: Carl Sherman
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: April 1, 2002
Publisher: International Medical News Group
Volume: 30 Issue: 4 Page: 12(1)

Article Type: Brief...

© 2009 BrightSurf.com